ArticleJournal of clinical pathology2023

Biomarker testing strategies in non-small cell lung cancer in the real-world setting: analysis of methods in the Prospective Central Lung Cancer Biomarker Registry (LungPath) from the Spanish Society of Pathology (SEAP).

Javier Martín-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.